Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 15/20 | 1.00 |
| ▸ | LMNA | P02545 | 12/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 10/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 1.00 |
| ▸ | HPGD | P15428 | 8/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 4/20 | 1.00 |
| ▸ | HKDC1 | Q2TB90 | 4/20 | 1.00 |
| ▸ | CCR6 | P51684 | 3/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | TNF | P01375 | 1/20 | 1.00 |
| ▸ | RUNX1 | Q01196 | 1/20 | 1.00 |
| ▸ | CBFB | Q13951 | 1/20 | 1.00 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 1.00 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 1.00 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 7/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.81 |
| ▸ | HTT | P42858 | 6/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8286963 | 0.91 | MAPT (0.84) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL9904910 | 0.91 | MAPT (0.87) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL8285454 | 0.89 | MAPT (1.00) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL8285453 | 0.87 | MAPT (1.00) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL8285451 | 0.86 | MAPT (1.00) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL13561203 | 0.80 | HSP90AA1 (0.74) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL10751474 | 0.79 | MAPT (0.64) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL12833640 | 0.77 | MAPT (0.62) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL10370782 | 0.76 | MAPT (0.67) | MAPTLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL14765018 | 0.74 | CYP1A2 (0.58) | MAPTLMNAALDH1A1NPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110257146-A1 | Method of Treating Kcnq Related Disorders Using Organozinc Compounds | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110257146-A1 | Method of Treating Kcnq Related Disorders Using Organozinc Compounds | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-10-20 | — | — | US | disclosed |
| WO-2007087424-A2 | METHOD OF TREATING KCNQ RELATED DISORDERS USING ORGANOZINC COMPOUNDS | THE JOHNS HOPKINS UNIVERSITY (US) | 2007-08-02 | — | — | WO | disclosed |
| WO-2005053609-A2 | METHODS OF NAD+-DEPENDENT DEACETYLASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 2005-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257146-A1 | Method of Treating Kcnq Related Disorders Using Organozinc Compounds | KCNQ3, KCNQ1, KCNQ5 | MAPT 3582/4885LMNA 2368/4885ALDH1A1 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.